Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-06-18

Clinical Trial Update: Albuminuria Reduction With Renin Angiotensin System Inhibitors in SCA Patients [NA]

View source ↗

Summary

A clinical trial update discusses whether renin-angiotensin system inhibitors reduce albuminuria in patients with sickle cell disease. The trial status is compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Sickle Cell Disease | NA | Status: COMPLETED